High-dose bicalutamide monotherapy for the treatment of prostate cancer
- 1 January 1996
- Vol. 47 (1) , 44-47
- https://doi.org/10.1016/s0090-4295(96)80008-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancerUrology, 1995
- Update of Monotherapy Trials with the New Anti-Androgen, Casodex (IC1176,334)European Urology, 1994
- I. A New Non-Steroidal AntiandrogenEuropean Urology, 1990
- The Response of Advanced Prostatic Cancer to a New Non-Steroidal Antiandrogen: Results of a Multicenter Open Phase II Study of CasodexEuropean Urology, 1990
- The Pharmacokinetics of Casodex in Prostate Cancer Patients after Single and during Multiple DosingEuropean Urology, 1990